Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China · Delayed Price · Currency is CNY 4.080
+0.020 (0.49%)
Jul 3, 2026, 3:00 PM CST
SHA:600572 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,351 | 11,302 | 11,680 | 12,979 | 12,156 | 12,850 | |
Market Cap Growth | -8.96% | -3.24% | -10.01% | 6.77% | -5.40% | 6.16% |
Enterprise Value | 9,754 | 10,968 | 11,398 | 12,136 | 11,898 | 13,766 |
Last Close Price | 4.08 | 4.30 | 4.34 | 4.53 | 4.15 | 4.23 |
PE Ratio | 21.11 | 23.83 | 18.77 | 21.94 | 33.95 | 6.37 |
Forward PE | - | 15.92 | 15.92 | 15.92 | 15.92 | 15.92 |
PS Ratio | 1.55 | 1.75 | 1.79 | 1.93 | 2.03 | 1.96 |
PB Ratio | 1.41 | 1.58 | 1.69 | 1.77 | 1.66 | 1.68 |
P/TBV Ratio | 1.54 | 1.74 | 1.86 | 2.00 | 1.92 | 1.93 |
P/FCF Ratio | 11.78 | 14.21 | 16.18 | 18.82 | 14.07 | 41.48 |
P/OCF Ratio | 10.22 | 11.99 | 11.54 | 14.44 | 10.52 | 14.42 |
PEG Ratio | - | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 |
EV/Sales Ratio | 1.46 | 1.69 | 1.75 | 1.80 | 1.98 | 2.10 |
EV/EBITDA Ratio | 10.61 | 12.74 | 12.37 | 10.75 | 12.35 | 14.39 |
EV/EBIT Ratio | 16.67 | 20.72 | 19.63 | 15.09 | 17.23 | 20.42 |
EV/FCF Ratio | 11.10 | 13.79 | 15.79 | 17.60 | 13.78 | 44.43 |
Debt / Equity Ratio | 0.02 | 0.04 | 0.06 | 0.17 | 0.16 | 0.20 |
Debt / EBITDA Ratio | 0.16 | 0.35 | 0.46 | 1.10 | 1.24 | 1.55 |
Debt / FCF Ratio | 0.17 | 0.38 | 0.59 | 1.80 | 1.39 | 4.82 |
Net Debt / Equity Ratio | -0.10 | -0.19 | -0.13 | -0.18 | -0.17 | -0.14 |
Net Debt / EBITDA Ratio | -0.77 | -1.59 | -0.97 | -1.18 | -1.32 | -1.13 |
Net Debt / FCF Ratio | -0.80 | -1.72 | -1.24 | -1.93 | -1.47 | -3.49 |
Asset Turnover | 0.66 | 0.65 | 0.62 | 0.61 | 0.54 | 0.64 |
Inventory Turnover | 2.72 | 2.44 | 2.39 | 2.30 | 2.27 | 2.62 |
Quick Ratio | 1.15 | 1.34 | 1.22 | 1.38 | 1.49 | 1.37 |
Current Ratio | 1.98 | 1.87 | 1.76 | 1.82 | 1.93 | 1.73 |
Return on Equity (ROE) | 6.93% | 6.99% | 9.23% | 9.20% | 6.15% | 32.90% |
Return on Assets (ROA) | 3.66% | 3.33% | 3.43% | 4.54% | 3.89% | 4.10% |
Return on Invested Capital (ROIC) | 7.13% | 6.84% | 8.14% | 11.71% | 8.54% | 9.06% |
Return on Capital Employed (ROCE) | 7.60% | 7.00% | 7.90% | 10.00% | 8.50% | 8.30% |
Earnings Yield | 4.67% | 4.20% | 5.33% | 4.56% | 2.95% | 15.70% |
FCF Yield | 8.49% | 7.04% | 6.18% | 5.31% | 7.11% | 2.41% |
Dividend Yield | 3.68% | 3.49% | 3.45% | 4.42% | 3.62% | 3.78% |
Payout Ratio | 79.06% | 80.87% | 84.11% | 71.02% | 136.92% | 4.21% |
Buyback Yield / Dilution | 3.29% | -0.28% | 3.20% | -0.55% | 1.10% | -2.71% |
Total Shareholder Return | 6.97% | 3.21% | 6.66% | 3.87% | 4.72% | 1.07% |